A novel topical HSP90 inhibitor (ctxt-102) in the treatment of mild to moderate plaque psoriasis
Ended Project Grant Awarded Last action
- Award ID
- R44AR071174
- Recipient
-
Regranion, LLC UEI MC1LNCYZJCK9
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,225,570
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date
- Originally
- Place of performance
- Mt Pleasant, SC 29464, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $571,536 | |
| Original award | $654,034 |
Quick answers
Who received award R44AR071174?
R44AR071174 was awarded to Regranion, LLC by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 26, 2017.
How much is award R44AR071174 worth?
$1,225,570 has been obligated on R44AR071174.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award